There is evidence for a role of inflammation in the etiology of lower urinary tract symptoms (LUTS), raising the possibility that use of nonsteroidal antiinflammatory drugs (NSAIDs) may inhibit the development or progression of LUTS. The authors examined the association between use of prescription and over-the-counter NSAIDs and LUTS among 1,974 men and 2,661 women in the Boston Area Community Health Survey (2002)(2003)(2004)(2005). Multivariableadjusted logistic regression was used to estimate odds ratios and 95% confidence intervals for LUTS, voiding symptoms, storage symptoms, and nocturia. There was no clear association between use of prescription or overthe-counter NSAIDs (compared with no NSAID use) and overall LUTS, voiding symptoms, or nocturia in men or women. However, over-the-counter NSAID use was positively associated with storage symptoms in women (odds ratio ¼ 1.37, 95% confidence interval: 1.03, 1.83), and there was a positive association between over-the-counter NSAID use and overall LUTS among women with a history of arthritis (odds ratio ¼ 2.09, 95% confidence interval: 1.20, 3.64). These results do not provide strong support for an association between NSAIDs and LUTS. However, the associations between over-the-counter NSAID use and certain urologic symptoms, particularly among women with arthritis, and the potential mechanisms involved should be evaluated in future studies.
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Lower urinary tract symptoms (LUTS) affect a large proportion of the population and are associated with reduced quality of life (1) . Several lines of evidence support a role of inflammation in the etiology of LUTS, raising the possibility that nonsteroidal antiinflammatory drugs (NSAIDs) may inhibit the development or lessen the severity of LUTS. Previous studies have reported a positive association between C-reactive protein levels and LUTS in both men and women (2) (3) (4) , and the presence of prostatic inflammatory infiltrates has been associated with LUTS and acute urinary retention in men (5) . Other evidence suggests that NSAIDs may affect urinary function by inhibiting cyclooxygenase 2 expression and synthesis of prostaglandins, which are involved in contraction of the bladder muscle (6, 7) . However, data on the association between NSAID use and LUTS are limited.
In the Olmsted County Study, NSAID use was inversely associated with incidence of LUTS in men with no history of urologic disease (8) . Further, prescription NSAIDs have been associated with improvements in nocturia and other urinary symptoms in clinical investigations (9) (10) (11) (12) (13) . In contrast, 2 large studies of men reported associations between NSAID use and increased risk of acute urinary retention (7) , nocturia, and benign prostatic hyperplasia (14) . Although these studies suggest that NSAID use may influence the development or progression of LUTS, the results are inconsistent and the data for women are limited to small clinical studies. We therefore examined the association between use of prescription and over-the-counter NSAIDs and LUTS in the Boston Area Community Health Survey, a population-based study of urologic symptoms in men and women.
MATERIALS AND METHODS

Study design and data collection
The Boston Area Community Health Survey is an epidemiologic study of symptoms suggestive of urologic disease conducted among 2,301 male and 3,202 female residents of Boston, Massachusetts. Additional details of the study design are described elsewhere (15) . Briefly, a multistage stratified cluster sampling design was used to recruit approximately equal numbers of participants in prespecified groups defined by age (30-39, 40- 
Lower urinary tract symptoms
We assessed urologic symptoms using the American Urological Association Symptom Index (AUA-SI), a widely used scale that is equivalent to the International Prostate Symptom Scale and is validated in men (16, 17) . A reliable, validated Spanish version of the scale also is available (18) . Although the American Urological Association Symptom Index has not, to our knowledge, been validated in women, previous studies indicate that women report scores from this scale similar to those of age-matched men (19, 20) .
The American Urological Association Symptom Index measures 7 urologic symptoms on a scale from 0 (never) to 5 (almost always), and the scores are summed to obtain a total score ranging from 0 to 35 (17) . We defined the presence of LUTS as a score 8 on the American Urological Association Symptom Index. We additionally evaluated the presence of storage (irritative) symptoms (total score 4 for frequency, urgency, and nocturia) and voiding (obstructive) symptoms (total score 5 for incomplete emptying, intermittency, weak stream, and hesitancy). These cutpoints are consistent with those from prior studies (21) and indicate the presence of moderate-to-severe urinary tract symptoms. We also evaluated nocturia separately, because of its common occurrence and impact on quality of life (22, 23) . Nocturia was defined as urinating at least twice nightly on average.
Analgesic use
Interviewers assessed use of prescription and overthe-counter analgesics during the past 4 weeks by direct observation/recording of medication labels, as well as by participant's self-report with prompts of indications and common brand names. We created a 3-level variable for use of any prescription NSAID (selective cyclooxygenase 2 inhibitors or nonselective NSAIDs, with or without overthe-counter NSAIDs), use of over-the-counter NSAIDs (24) . In additional analyses, we estimated associations separately for cyclooxygenase 2 inhibitors, nonselective prescription NSAIDs, aspirin, ibuprofen, and acetaminophen. We considered opiate use as a potential confounder but did not report associations with opiates because of the small number of users, overlap between use of opiates and other analgesics, and potential differences in the mechanism of action.
Covariates
We selected covariates to evaluate as potential confounders on the basis of biologic plausibility or evidence of an association with LUTS in previous analyses from the Boston Area Community Health Survey (25) . Socioeconomic status was constructed on the basis of standardized household income and education for the northeastern United States and categorized as low, middle, or high (26) . Body mass index was calculated from measured weight and height and categorized (<25, 25-<30, 30 kg/m 2 ). Physical activity was assessed by using the Physical Activity Scale for the Elderly and was categorized as low (<100), medium (100-249), or high (250) (27) . Additional categorical variables evaluated included self-reported health status (poor/ fair vs. good/very good/excellent), health insurance status (uninsured vs. insured), marital status (married/living with a partner, divorced/separated/widowed, single/never married/other), poverty status, education (less than high school, high school, more than high school), alcohol use (0, 1-<5, 5-<15, 15-<30, 30 g/day), smoking status (never, past, current), binary variables for opiate or statin use during the past 4 weeks, and binary comorbidity variables. Arthritis, hypertension, cardiovascular disease, type I or II diabetes, urinary tract infection, and asthma were assessed by using the question, ''Have you ever been told by a health care provider that you have or had . . .?'' Current depression was defined as 5 of 8 symptoms on the abridged Center for Epidemiologic Studies Depression Scale (28) . We also considered C-reactive protein as a potential confounder (<1, 1-3, >3 mg/L) in a subanalysis of men and women who provided a 20-mL blood specimen at baseline. Creactive protein was assayed by using an immunoturbidimetric assay as described previously (2), and levels were available for 1,650 men and 1,532 women in our population. However, adjusting for C-reactive protein did not materially change the estimates, and we omitted it from the final model out of concern that it might be on the causal pathway.
Statistical analysis
Our analytical goal was to examine the association between NSAID use and LUTS, without confounding by established urologic disease or associated conditions. We therefore excluded participants who reported treatment for urologic disease or a history of conditions that might influence bladder function, including genitourinary cancer, neurogenic bladder (clinician-diagnosed problem with bladder emptying because of nerve/muscle function), prolapsed bladder, Parkinson's disease, multiple sclerosis, bladder/prostate surgery, treatment for urinary incontinence or other urinary conditions, or catheter use recommended by a health-care provider. After these exclusions, our analysis included 1,974 men and 2,661 women.
We used unconditional logistic regression to model multivariable-adjusted odds ratios and 95% confidence intervals for the association between NSAID use and LUTS. All analyses were conducted separately for men and women by using SAS, version 9.2, software (SAS Institute, Inc., Cary, North Carolina) and SUDAAN, version 10.0.1, software (RTI International, Research Triangle Park, North Carolina). We used multiple imputation to replace missing data with plausible values (29) ; less than 1% of the data were missing for most variables, with the exception of income which was missing differentially by race/ethnicity. A total of 25 multiple imputations were performed separately by gender and race/ethnicity by using all relevant variables. Medication use was not imputed; instead, individuals with missing data on NSAID use were assumed to be nonusers. To account for the sampling design, all analyses were weighted according to the 2000 US Census by using weights inversely proportional to the probability of selection. This allows estimates to be interpreted as representative of the eligible subpopulation of Boston, Massachusetts.
We used a backward selection procedure to determine the structure of the final model. Only covariates that changed the odds ratio for the association between NSAID use and any of the 4 outcomes by >10% were included in the model. In our final model, we adjusted for age group, race/ethnicity, self-reported health status, marital status, history of arthritis, and current depression. Controlling for additional covariates, including statin use, alcohol use, urinary tract infection, and history of other comorbidities, did not materially change the estimates. In additional analyses, we stratified by and examined interactions with arthritis status, cardiovascular disease, and age (<55 vs. 55 years) to examine whether associations differed by age or among those with an indication for NSAID use. All P values were 2 sided.
RESULTS
Characteristics of the study population by NSAID use are presented in Table 1 . LUTS were present in 13.8% of individuals with no recent NSAID use, 17.3% of prescription NSAID users, and 15.8% of individuals with over-thecounter NSAID use only. Nocturia was reported by 40.3% of prescription NSAID users, compared with 25.0% of nonusers and 24.0% of over-the-counter NSAID users. Individuals who used prescription NSAIDs were older, on average, than individuals without prescription NSAID use, and users of prescription or over-the-counter NSAIDs were more likely to be female and white than nonusers. Further, users of prescription NSAIDs tended to be less physically active, Table continues less likely to smoke, and more likely to be obese and to report poor/fair health status. The presence of comorbidities also varied by NSAID use status, particularly for arthritis, which was reported by 56.0% of prescription NSAID users, 23.2% of over-the-counter NSAID users, and 13.2% of nonusers. C-reactive protein levels and statin use were highest among prescription NSAID users, intermediate among overthe-counter NSAID users, and lowest among nonusers, most likely because of age differences or the presence of cardiovascular disease or other indications for NSAID use. There was no clear association between NSAID use and total LUTS among men or women ( Table 2 ). The multivariable-adjusted odds ratios for prescription NSAID use and LUTS were 0.70 (95% confidence interval (CI): 0.35, 1.38) for women and 0.81 (95% CI: 0.34, 1.92) for men, and the corresponding estimates for over-the-counter NSAID use were 1.16 (95% CI: 0.81, 1.66) and 0.96 (95% CI: 0.60, 1.53). However, we observed a statistically significant positive association between over-the-counter NSAID use and storage symptoms in women (odds ratio (OR) ¼ 1.37, 95% CI: 1.03, 1.83) and a positive but nonsignificant association in men (OR ¼ 1.37, 95% CI: 0.96, 1.97). There was no association between prescription NSAID use and storage symptoms in women or men, although the confidence intervals did not preclude a positive association. In addition, there was no clear association between prescription or over-the-counter NSAID use and either voiding symptoms or nocturia.
Because of possible confounding by indication, we stratified by self-reported arthritis (Table 3) and cardiovascular disease status (results not shown). P values for interaction suggested potential interactions with both arthritis (P 0.04) and cardiovascular disease (P 0.10). In stratified analyses, most associations were similar by arthritis status; for example, the magnitude of the association between overthe-counter NSAID use and storage symptoms was almost identical in women with (OR ¼ 1.38, 95% CI: 0.81, 2.33) and without (OR ¼ 1.41, 95% CI: 1.00, 1.97) arthritis, Abbreviations: NSAID, nonsteroidal antiinflammatory drug; SE, standard error. a Estimates are inversely weighted to the probability of selection; the percentages shown are column percentages and may not sum to 100 because of rounding.
b Use of prescription NSAIDs with or without over-the-counter NSAIDs. c Total numbers with C-reactive protein: 1,527 with no NSAID use; 153 with prescription NSAID use (with or without over-the-counter NSAIDs); and 1,502 with over-the-counter NSAID use only.
d Defined as a history of coronary artery bypass, angioplasty, myocardial infarction, angina, arrhythmia requiring a pacemaker, heart rhythm disturbance, congestive heart failure, transient ischemic attack, stroke, carotid artery surgery, intermittent claudication, surgery or angioplasty for arterial disease of the leg, pulmonary embolism, aortic aneurysm, deep vein thrombosis, Raynaud's disease, or peripheral vascular disease.
although neither estimate was statistically significant. However, we observed a significant positive association between over-the-counter NSAID use and overall LUTS among women with arthritis (OR ¼ 2.09, 95% CI: 1.20, 3.64) that was not present among women without arthritis (OR ¼ 0.97, 95% CI: 0.62, 1.53). In addition, there was a statistically significant inverse association between prescription NSAID use and storage symptoms among men without arthritis (OR ¼ 0.34, 95% CI: 0.12, 0.94); however, this estimate was based on a small number of men with the exposure and outcome of interest (n ¼ 8), and there was no evidence of an association among men with arthritis. No other associations were statistically significant, although the confidence intervals for several estimates were wide. In analyses stratified by cardiovascular disease status, none of the estimates was statistically significant, and there was no clear evidence that the presence of cardiovascular disease modified the association of NSAIDS with LUTS.
We also evaluated effect modification by age by examining associations separately among individuals <55 vs. 55 years of age (Table 4) . P values for interaction between NSAID use and continuous age ranged from 0.05 to 0.60. Positive associations tended to be stronger among younger individuals; for example, the association between overthe-counter NSAID use and storage symptoms in women was statistically significant among women <55 years of age (OR ¼ 1.57, 95% CI: 1.08, 2.28) but not among women 55 years of age (OR ¼ 1.10, 95% CI: 0.71, 1.71). In addition, there was a borderline significant positive association between prescription NSAID use and nocturia in younger men that was not present in older men. However, there was no clear, consistent evidence of effect modification by age, although some analyses were based on a small number of affected individuals.
To evaluate the possibility that users of over-the-counter analgesics are more likely to develop or report LUTS, we additionally examined the association with acetaminophen use (Table 5) . In our population, 34% of participants reported no NSAID or acetaminophen use, 5% used prescription NSAIDs (with or without other analgesics), 32% used over-the-counter NSAIDs only, 16% used acetaminophen only, and 13% used both over-the-counter NSAIDs and acetaminophen. Use of both over-the-counter NSAIDs and acetaminophen was positively associated with LUTS (OR ¼ 1.81, 95% CI: 1.04, 3.14), voiding symptoms (OR ¼ 2.03, 95% CI: 1.09, 3.81), and storage symptoms (OR ¼ 1.80, 95% CI: 1.19, 2.74) in women and storage symptoms in men (OR ¼ 1.99, 95% CI: 1.11, 3.59). In addition, there was a borderline significant positive association between use of both over-the-counter NSAIDs and acetaminophen and nocturia in women. We did not observe any significant associations with use of over-the-counter NSAIDs or acetaminophen alone.
In additional analyses, we examined associations separately for use of cyclooxygenase 2 inhibitors versus nonselective prescription NSAIDs, aspirin versus ibuprofen, and prescription NSAIDs alone or in combination with overthe-counter NSAIDs (results not shown). Several of these analyses were limited by the small number of individuals with the exposure and outcome of interest. However, there was no clear evidence of an association with any of these exposures.
DISCUSSION
The results of this large, population-based study of urologic symptoms do not support an inverse association between NSAID use and LUTS in men or women. We did not observe associations between use of prescription or overthe-counter NSAIDs and overall LUTS, voiding symptoms, or nocturia. However, the positive association between overthe-counter NSAID use and storage symptoms, which was stronger among individuals using both over-the-counter NSAIDs and acetaminophen, and the positive association between over-the-counter NSAID use and LUTS in women with arthritis suggest a possible role of residual or poorly controlled pain in the development or reporting of LUTS.
In a prior analysis of Boston Area Community Health Survey participants (n ¼ 3,752), C-reactive protein levels were positively associated with urologic symptoms, in particular nocturia (for C-reactive protein >3 vs. <1 mg/L, OR ¼ 2.09) and straining (OR ¼ 3.36) in men and incomplete emptying (OR ¼ 2.32) and weak stream (OR ¼ 2.68) in women (2) . Analyses of 2,337 men aged 60 years in the Third National Health and Nutrition Examination Survey (3) and 442 men aged 40-79 years in the Olmsted County Study (4) also support positive associations between Creactive protein and LUTS (ORs ¼ 1.5-2.5), and other evidence indicates that certain NSAIDs may decrease Creactive protein levels (30) , suggesting a possible mechanism for an inverse association between NSAIDs and LUTS. Inflammatory infiltrates are a common finding in prostate tissue from men with benign prostatic hyperplasia (31) (32) (33) (34) , and 2 studies have reported positive associations between the presence of prostatic inflammatory infiltrates and LUTS (35, 36) , further supporting a role of inflammation in the etiology of LUTS. Prostatic inflammation may influence LUTS by stimulating prostate growth or inhibiting prostatic apoptosis (5), thus increasing prostate volume (32, 36) , which may contribute to urinary problems due to urethral constriction or bladder obstruction. Cyclooxygenase 2 may be an important mediator of prostate cell growth related Abbreviations: CI, confidence interval; NSAID, nonsteroidal antiinflammatory drug; OR, odds ratio. a Adjusted for age (30-39, 40-49, 50-59, 60 years), race/ethnicity (black, Hispanic, white), self-reported health status (fair/poor vs. excellent/ very good/good), marital status (married/living with a partner, divorced/separated or widowed, single/never married or other), and depression.
b Use of prescription NSAIDs with or without over-the-counter NSAID use.
to inflammation, as evidenced by positive associations between increased cyclooxygenase 2 expression and cellular proliferation in prostate epithelial tissue (37). Cyclooxygenase 2-related pathways also appear to be important in bladder function. Prostaglandins are involved in contraction of the bladder muscle (38) , and a study by Park et al. (39) found that stretching murine bladder muscle cells resulted in upregulation of both cyclooxygenase 2 and prostaglandin E 2 . In addition, case studies and a large study of Dutch men support a positive association between NSAIDs and acute urinary retention (7, 38) , suggesting that NSAID-induced inhibition of cyclooxygenase 2 expression and prostaglandin synthesis has the potential to inhibit bladder contraction. Excess prostaglandins due to inflammation therefore may influence bladder function and the development of urinary symptoms in both men and women. Although plausible mechanisms exist for an association between NSAIDs and LUTS, results from previous studies of this association are inconsistent. In an analysis of 2,447 men aged 40-79 years in the Olmsted County Study, St. Sauver et al. (8) observed significant inverse associations between daily use of prescription or over-the-counter NSAIDs and incidence of several urinary outcomes, including LUTS, voiding symptoms, storage symptoms, and nocturia (multivariable-adjusted hazard ratios ¼ 0.59-0.70), in men with no history of urologic disease. The results were similar for use of aspirin and nonaspirin NSAIDs and were more strongly inverse among older men (8) . In contrast, an analysis of 34,694 men aged 55-74 years in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial found weak (OR ¼ 1.2) but statistically significant positive associations between regular aspirin or ibuprofen use in the past year and risk of nocturia and physician-diagnosed benign prostatic hyperplasia (14) , while the Massachusetts Male Aging Study reported no significant association (OR ¼ 1.2) between aspirin use and clinical benign prostatic hyperplasia among 1,019 men aged 40-70 years (40) . Several small clinical investigations (n ¼ 30-93) have observed associations between treatment with specific prescription NSAIDs and improvements in urinary symptoms, including nocturia, frequency, and urgency (9) (10) (11) (12) (13) . Although a few of these studies included women, no prior populationbased studies of NSAIDs and LUTS in women are available. Inconsistencies in the results of prior studies could be due to differences in population characteristics, such as the presence of existing urinary disease, or confounding by indications for NSAID use or other individual-level characteristics. In the Boston Area Community Health Survey, NSAID use and urologic symptoms were assessed at the same point in time, which may have influenced our results if NSAID use prevents the onset of LUTS in individuals without urologic symptoms but does not influence the course of disease in symptomatic individuals, or if participants modified their NSAID use in response to urologic symptoms. Previous studies differ in how NSAID use was defined, which may have influenced the results if the frequency or type of NSAID use is important. Although we do not have data on the frequency or duration of NSAID use, we would expect that individuals on prescription NSAIDs would be more likely to regularly use their medication and may therefore be more likely to exhibit an association. Although our power to detect associations with prescription NSAID use was somewhat limited by the modest number of users, there was no clear evidence suggesting an inverse association between prescription NSAID use and LUTS. This is the first population-based study to examine the association between NSAID use and LUTS in women. Our results suggest that individuals with residual pain, such as women with arthritis who use over-the-counter NSAIDs only or individuals who use multiple types of over-thecounter analgesics, may experience or report more urologic Abbreviations: CI, confidence interval; NSAID, nonsteroidal antiinflammatory drug; OR, odds ratio. a Adjusted for age (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) , 50-59, 60 years), race/ethnicity (black, Hispanic, white), self-reported health status (fair/poor vs. excellent/very good/good), marital status (married/living with a partner, divorced/separated or widowed, single/never married or other), arthritis, and depression; adjusting for additional covariates did not materially change the results.
b Use of prescription NSAIDs with or without over-the-counter NSAIDs.
symptoms than nonusers and individuals with pain controlled by prescription NSAIDs. This may be due to functional incontinence related to inability to reach the bathroom in time or a perceived higher level of symptoms due to heightened awareness of the effort involved in reaching the bathroom. Conversely, individuals with arthritis or other painful conditions may have higher systemic levels of inflammation and prostaglandins, which could contribute to urologic symptoms because of their effect on the bladder and/or prostate. These associations and the potential mechanisms involved should be evaluated in future studies.
As noted above, NSAID use and urologic symptoms were assessed at the same point in time, and we were unable to examine the temporal relation between exposure and outcome. Future studies of longitudinal data from the ongoing follow-up of Boston Area Community Health Survey participants may help to address the temporal relation as well as the influence of duration of NSAID use. Our study had a small number of users of certain NSAIDs, such as nonselective prescription NSAIDs, which may have limited our ability to detect an association with these NSAID classes. In addition, we were unable to examine associations with urinary incontinence or individual voiding or storage symptoms, other than nocturia, because of the small number of affected individuals. However, our analysis also had several strengths, including its size, the use of community-based sampling, and the diversity of the population with respect to age, gender, race/ethnicity, and socioeconomic status. In addition, we collected data on recent use of both over-thecounter and prescription NSAIDs, as well as detailed data on potential confounders and effect modifiers.
In summary, our results do not provide support for an inverse association between NSAID use and LUTS in men or women. However, the possible positive association with over-the-counter analgesics, which may be due to residual pain, should be evaluated in future studies. Our results suggest that adequate treatment of arthritis and other painful conditions may be associated with fewer urologic symptoms. This is an important area for future research, given the high prevalence of urologic symptoms and the negative consequences of these symptoms on quality of life (41) .
